back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$138,060
+78,000 vol $1.77 each |
278,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,100
+130,000 vol $1.77 each |
||
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,100
+130,000 vol $1.77 each |
330,000 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,040
+52,000 vol $1.77 each |
382,000 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,000
+200,000 vol $1.65 each |
200,000 | |
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
15 - Acquisition or disposition under a prospectus
|
+15,000 vol |
15,000 | |
| Filed 2017-02-27 Tx date 2016-11-27 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Public Offering 2017
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-27 Tx date 2017-02-21 |
$ACST
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
15 - Acquisition or disposition under a prospectus
|
$43,500
+30,000 vol $1.45 each |
30,000 | |
| Filed 2016-11-30 Tx date 2016-11-27 |
$APO
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-30 Tx date 2016-11-27 |
$APO
Acasti Pharma Inc. |
O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|